There may be something else that needs addressing
Tirzepatide (Zepbound) : SURMOUNT-1/-2 trials show 15%22% average weight loss at 72 weeks, depending on dose and whether participants had diabetes
References Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF
Semaglutide for Weight Loss in Non-Diabetics in Dallas, TX If youre considering semaglutide for weight loss in non-diabetics, professional medical guidance is essential
Who should be cautious: People who are pregnant or nursing, have underlying health conditions, or use prescription medications may need extra caution and should discuss with a healthcare provider before use